Fosaprepitant
| CAS No. | 172673-20-0 |
|---|---|
| MDL No. | N/A |
| MF | C23H22F7N4O6P |
| MW | 614.40 |
| InChI Key | BARDROPHSZEBKC-OITMNORJSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Fosaprepitant is a morpholine derivative, specifically the (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ether of (3-{[(2R,3S)-3-(4-fluorophenyl)-2-hydroxymorpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid. It functions as an antiemetic and neurokinin-1 receptor antagonist, and acts as a prodrug. It belongs to morpholines, triazoles, cyclic acetals, phosphoramides, and (trifluoromethyl)benzenes. It is the conjugate acid of fosaprepitant(2-).
| CAS No. | 172673-20-0 |
|---|---|
| Product Name | Fosaprepitant |
Biological Targets
TACR1
Associated Conditions
cancer·multiple myeloma·Chemotherapy-induced nausea and vomiting·Vomiting·Nausea and vomiting·
* The information provided here is compiled from public sources and is for reference only.
